Literature DB >> 16060628

Novel binding of beryllium to dicarboxyimidazole-based model compounds and polymers.

Paul G Plieger1, Deborah S Ehler, Brandy L Duran, Tammy P Taylor, Kevin D John, Timothy S Keizer, T Mark McCleskey, Anthony K Burrell, Jeffrey W Kampf, Thomas Haase, Paul G Rasmussen, Jennifer Karr.   

Abstract

The ligand 4,5-dicarboxyimidazole (H(2)DCI) and its methyl derivative 1-methyl-4,5-dicarboxyimidazole (H(2)MDCI) have been shown to bind to Be(II) forming a zwitterionic species that has been structurally characterized. A new dicarboxyimidazole-based polymer has been prepared and its Be-binding properties have been studied using NMR ((1)H and (9)Be) and fluorescence spectroscopy; it represents a rare example of beryllium binding to a polymer. Models of the mononuclear and polymeric Be(II)-binding sites have been studied using density functional theory (DFT), and the (9)Be NMR chemical shifts of these model materials have been calculated for the purpose of direct comparison to experimentally observed values. Differences in the binding modes of the mononuclear and polymeric species are discussed.

Entities:  

Year:  2005        PMID: 16060628     DOI: 10.1021/ic050680c

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  3 in total

1.  Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease.

Authors:  James A Snyder; Eugene Demchuk; Erin C McCanlies; Christine R Schuler; Kathleen Kreiss; Michael E Andrew; Bonnie L Frye; James S Ensey; Marcia L Stanton; Ainsley Weston
Journal:  J R Soc Interface       Date:  2008-07-06       Impact factor: 4.118

2.  trans-Diaqua-bis[5-carb-oxy-4-carboxyl-ato-2-(4-pyridinio)-1H-imidazol-1-ido-κN,O]iron(II).

Authors:  Xia Li; Wei Liu; Ben-Lai Wu; Hong-Yun Zhang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-06-24

3.  Towards more effective beryllium chelation: an investigation of second-sphere hydrogen bonding.

Authors:  Tyson N Dais; David J Nixon; Penelope J Brothers; William Henderson; Paul G Plieger
Journal:  RSC Adv       Date:  2020-11-04       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.